Search results

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 March 2011

Recommendation ID TA217/1 Question Research is needed to generate robust and relevant data on the effects of treating people with Alzheimer's

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 January 2013

Recommendation ID TA272/1 Question Research on second-line treatments for transitional cell carcinoma of the urothelial tract is needed

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 February 2011

Recommendation ID TA216/1 Question Research should be carried out to compare the clinical effectiveness of bendamustine with chlorambucil

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 December 2018

Recommendation ID TA553/1 Question Proposals for further data collection in the Cancer Drugs Fund include:- recurrence-free survival- distant

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 June 2013

Recommendation ID TA287/2 Question Research into the long-term treatment effects of rivaroxaban is needed. Any explanatory notes(if

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 March 2011

Recommendation ID TA217/2 Question Research is needed on the impact of treating Alzheimer's disease on mortality and institutionalisation

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 April 2019

Recommendation ID TA574/1 Question What are the cost associated with best supportive care? Any explanatory notes(if applicable)

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 May 2011

Recommendation ID TA223/1 Question A trial comparing the long-term effectiveness (beyond 24 weeks) of cilostazol, naftidrofuryl oxalate

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 July 2014

Recommendation ID TA319/2 Question Further research into whether concomitant dacarbazine enhances the clinical effectiveness of ipilimumab

Type:

Evidence Uncertainties (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

01 October 2011

Recommendation ID TA236/2 Question Further research into whether ticagrelor is particularly beneficial in any clinical or biological subgroups

Type:

Evidence Uncertainties (Remove filter)